# FDA Inspection 1209420 - Sinopharm Weiqida Pharmaceutical Co. Ltd. - May 25, 2023

Source: https://www.keypedia.com/records/fda_inspections/sinopharm-weiqida-pharmaceutical-co-ltd/b4ad5182-3f8a-40cb-afd1-d9e89487b422
Source feed: FDA_Inspections

> FDA Inspection 1209420 for Sinopharm Weiqida Pharmaceutical Co. Ltd. on May 25, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209420
- Company Name: Sinopharm Weiqida Pharmaceutical Co. Ltd.
- Inspection Date: 2023-05-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1028876 - 2017-07-21](https://www.keypedia.com/records/fda_inspections/sinopharm-weiqida-pharmaceutical-co-ltd/ca08cd7f-2720-4dff-8768-f5fee63a1c6c)
- [FDA Inspection 932412 - 2015-05-01](https://www.keypedia.com/records/fda_inspections/sinopharm-weiqida-pharmaceutical-co-ltd/cf857a72-794c-49a5-bf26-86df324414ec)

Company: https://www.keypedia.com/companies/sinopharm-weiqida-pharmaceutical-co-ltd/84a9a7f6-77bd-4e05-b016-5ccda3f0ea97

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c